Comparison of clinical outcome after first-line platinum-based chemotherapy in different types of KRAS mutated advanced non-small-cell lung cancer

Wouter W. Mellema, Lucie Masen-Poos, Egbert F. Smit, Lizza E. L. Hendriks, Joachim G. Aerts, Arien Termeer, Martijn J. Goosens, Hans J. M. Smit, Michel M. van den Heuvel, Anthonie J. van der Wekken, Gerarda J. M. Herder, Frans H. Krouwels, Jos A. Stigt, Ben E. E. M. van den Borne, Tjeerd J. Haitjema, Agnes J. Staal-Van den Brekel, Robbert C. van Heemst, Ellen Pouw, Anne-Marie C. Dingemans

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)249-254
JournalLung Cancer
Volume90
Issue number2
DOIs
Publication statusPublished - Nov 2015

Keywords

  • Non-small cell lung cancer
  • KRAS mutation
  • Chemotherapy
  • Outcome
  • Type of KRAS mutation

Cite this